Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips [Seeking Alpha]
Sana Biotechnology, Inc. (SANA)
Company Research
Source: Seeking Alpha
SC451's planned 2026 IND is the primary catalyst going forward. In my view, this is their make-or-break catalyst this year. A favorable Phase 1 trial could rapidly re-rate the stock even higher, especially since it targets a sizeable TAM in TD1. However, by now, I think SANA's capital constraints can become a factor that limits their ability to progress their R&D further without a partner. SANA's valuation looks rich compared to its peers and its early-stage pipeline. I remain optimistic about their science, but I'd wait for dips. J Studios/DigitalVision via Getty Images Sana Biotechnology, Inc. ( SANA ) is a biotech company that develops an ex vivo hypoimmune therapy and an in vivo fusogen-based delivery system. This way, they can help treat cancer and autoimmune diseases. Their ex vivo platform This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such
Show less
Read more
Impact Snapshot
Event Time:
SANA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SANA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SANA alerts
High impacting Sana Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
SANA
News
- Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Sana Biotechnology (NASDAQ:SANA) had its price target raised by analysts at Bank of America Corporation from $6.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication [Yahoo! Finance]Yahoo! Finance
- Sana Biotechnology (NASDAQ:SANA) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SANA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StreetMarketBeat
SANA
Earnings
- 8/11/25 - Beat
SANA
Sec Filings
- 1/14/26 - Form 8-K
- 1/6/26 - Form 4
- 1/6/26 - Form 4
- SANA's page on the SEC website